Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Bizzozero

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
EMBO Molecular Medicine|May 19, 2026
WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancerKristi Buzo, Laura Bizzozero, Marilena Lentini, et al.
Journal of Translational Medicine|November 23, 2023
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancerAntonio Agostini, Ilaria Guerriero, Geny Piro, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
EMBO Molecular Medicine|May 19, 2026
WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancerKristi Buzo, Laura Bizzozero, Marilena Lentini, et al.
Journal of Translational Medicine|November 23, 2023
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancerAntonio Agostini, Ilaria Guerriero, Geny Piro, et al.
Pageof 2